Renewed interest in cancer immunotherapy with the tumor necrosis factor superfamily molecules Koji TamadaLieping Chen Review 27 September 2005 Pages: 355 - 362
Structure and function of ETAA16: a novel cell surface antigen in Ewing’s tumours A. BorowskiU. DirksenE. M. Schneider Original Article 08 July 2005 Pages: 363 - 374
Adenoviral-mediated transfer of human wild-type p53, GM-CSF and B7-1 genes results in growth suppression and autologous anti-tumor cytotoxicity of multiple myeloma cells in vitro Su-Ping RenChu-Tse WuLi-Sheng Wang Original Article 02 July 2005 Pages: 375 - 385
Human T lymphocyte responses against lung cancer induced by recombinant truncated mouse EGFR Bing HuYu-quan WeiXiao-wei Zhang Original Article 19 October 2005 Pages: 386 - 393
Interferon-α/β upregulate IL-15 expression in vitro and in vivo: analysis in human hepatocellular carcinoma cell lines and in chronic hepatitis C patients during interferon-α/β treatment Kouzaburo YamajiShigeki NabeshimaJun Hayashi Original Article 22 July 2005 Pages: 394 - 403
Efficacy of adjuvant Immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials Junichi SakamotoSatoshi MoritaMeta-Analysis Group of the Japanese Society for Cancer of the Colon Rectum Original Article 20 August 2005 Pages: 404 - 411
Interleukin-2/liposomes potentiate immune responses to a soluble protein cancer vaccine in mice Dean JohnstonSandra R. ReynoldsJean-Claude Bystryn Original Article 06 September 2005 Pages: 412 - 419
Adjuvant IL-15 does not enhance the efficacy of tumor cell lysate-pulsed dendritic cell vaccines for active immunotherapy of T cell lymphoma Erin GatzaCraig Y. Okada Original Article 15 July 2005 Pages: 420 - 432
Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma A.N. AlexanderM.K. HuelsmeyerD.M. Vail Original Article 18 June 2005 Pages: 433 - 442
Role of tumour-associated N-glycolylated variant of GM3 ganglioside in cancer progression: effect over CD4 expression on T cells Joel de LeònAudry FernándezLuis E. Fernández Original Article 06 October 2005 Pages: 443 - 450
Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients J. B. A. G. HaanenA. BaarsA. J. M. van den Eertwegh Original Article 21 July 2005 Pages: 451 - 458
Importance of signaling via the IFN-α/β receptor on host cells for the realization of the therapeutic benefits of cyclophosphamide for mice bearing a large MOPC-315 tumor Margalit B. MokyrAaron T. PlaceVE Ted Valli Original Article 18 June 2005 Pages: 459 - 468
A new dendritic cell vaccine generated with interleukin-3 and interferon-β induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients Myrto TrakatelliMichel ToungouzThierry Velu Short Communication 20 August 2005 Pages: 469 - 474
Cancer Immunotherapy 2005: Mainz, Germany, 12–13 May 2005 C. M. BrittenC. GouttefangeasS. Kreiter Meeting Report 29 September 2005 Pages: 475 - 480